1. Home
  2. LQDA vs TKC Comparison

LQDA vs TKC Comparison

Compare LQDA & TKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$77.99

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Turkcell Iletisim Hizmetleri AS

TKC

Turkcell Iletisim Hizmetleri AS

HOLD

Current Price

$5.82

Market Cap

4.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
TKC
Founded
2004
1993
Country
United States
Turkey
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.9B
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
LQDA
TKC
Price
$77.99
$5.82
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
$41.00
N/A
AVG Volume (30 Days)
2.1M
2.1M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
2.52%
EPS Growth
51.81
N/A
EPS
0.52
N/A
Revenue
$158,320,000.00
N/A
Revenue This Year
$278.87
$31.20
Revenue Next Year
$57.13
$24.27
P/E Ratio
$148.19
$26.98
Revenue Growth
1031.18
N/A
52 Week Low
$16.51
$5.35
52 Week High
$82.96
$7.18

Technical Indicators

Market Signals
Indicator
LQDA
TKC
Relative Strength Index (RSI) 56.17 46.86
Support Level $70.28 $5.52
Resistance Level $82.96 $6.12
Average True Range (ATR) 4.58 0.10
MACD -0.89 0.00
Stochastic Oscillator 61.43 54.76

Price Performance

Historical Comparison
LQDA
TKC

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Techfin, and Other. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

Share on Social Networks: